rasagiline has been researched along with Cardiac Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amit, T; Bar-Am, O; Berdichevski, A; Binah, O; Kleiner, Y; Liani, E; Maor, G; Reiter, I; Youdim, MB | 1 |
1 other study(ies) available for rasagiline and Cardiac Diseases
Article | Year |
---|---|
TVP1022 and propargylamine protect neonatal rat ventricular myocytes against doxorubicin-induced and serum starvation-induced cardiotoxicity.
Topics: Animals; Animals, Newborn; Antibiotics, Antineoplastic; Apoptosis; bcl-2-Associated X Protein; Cardiotonic Agents; Caspase 3; Cell Line, Tumor; Cells, Cultured; Doxorubicin; Female; Heart Diseases; Heart Ventricles; Humans; Indans; Myocytes, Cardiac; Pargyline; Propylamines; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Stereoisomerism | 2008 |